Although we report 1 patient with TET2 biallelic mutant, TP53-mutant AML who responded well to 5′-Aza (UPN33), all other patients with biallelic TET2 mutations were WT for TP53. This evidence concerns the gene TP53 and acute myeloid leukemia.